Literature DB >> 2725870

Prevalence of medically diagnosed dementia in a defined United States population: Rochester, Minnesota, January 1, 1975.

E Kokmen1, C M Beard, K P Offord, L T Kurland.   

Abstract

Using the centralized diagnostic data resource for the population of Rochester, Minnesota, we determined the prevalence of medically diagnosed dementia for this community. There were 289 individuals with dementia who were residing in Rochester on January 1, 1975: 208 women and 81 men. The overall age- and sex-adjusted rates per 100,000 population were 342 for all dementias and 227 for Alzheimer's disease. Prevalence rates increased with age for both sexes. Limiting the denominator to persons greater than or equal to 65 years, age-adjusted rates per 100,000 population for men and women were 3,452 and 3,466 (or about 3.5%), respectively, for dementia and 2,007 and 2,675 (2.0 and 2.7%), respectively, for Alzheimer's disease.

Entities:  

Mesh:

Year:  1989        PMID: 2725870     DOI: 10.1212/wnl.39.6.773

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  22 in total

1.  Tacrine for Alzheimer's disease. Costs and benefits.

Authors:  D Knopman
Journal:  Pharmacoeconomics       Date:  1995-04       Impact factor: 4.981

Review 2.  Alzheimer's disease and mild cognitive impairment.

Authors:  Brendan J Kelley; Ronald C Petersen
Journal:  Neurol Clin       Date:  2007-08       Impact factor: 3.806

3.  Rare Variants and Transcriptomics in Alzheimer disease.

Authors:  Crystal Humphries; Martin A Kohli
Journal:  Curr Genet Med Rep       Date:  2014-06-01

4.  [Presenile dementia in memory clinics--incidence rates and clinical features].

Authors:  H Bickel; K Bürger; H Hampel; Y Schreiber; A Sonntag; B Wiegele; H Förstl; A Kurz
Journal:  Nervenarzt       Date:  2006-09       Impact factor: 1.214

5.  Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum.

Authors:  D Campion; C Dumanchin; D Hannequin; B Dubois; S Belliard; M Puel; C Thomas-Anterion; A Michon; C Martin; F Charbonnier; G Raux; A Camuzat; C Penet; V Mesnage; M Martinez; F Clerget-Darpoux; A Brice; T Frebourg
Journal:  Am J Hum Genet       Date:  1999-09       Impact factor: 11.025

6.  Dementia in the USA: state variation in prevalence.

Authors:  D Koller; Julie P W Bynum
Journal:  J Public Health (Oxf)       Date:  2014-10-20       Impact factor: 2.341

7.  Prevalence of dementia in an elderly rural population: effects of age, sex, and education.

Authors:  M Prencipe; A R Casini; C Ferretti; M T Lattanzio; M Fiorelli; F Culasso
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-06       Impact factor: 10.154

8.  The prevalence and causes of dementia in people under the age of 65 years.

Authors:  R J Harvey; M Skelton-Robinson; M N Rossor
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-09       Impact factor: 10.154

Review 9.  Seizures in elderly patients with dementia: epidemiology and management.

Authors:  Mario Mendez; Gerald Lim
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

10.  Apolipoprotein E: risk factor for Alzheimer disease.

Authors:  M S Tsai; E G Tangalos; R C Petersen; G E Smith; D J Schaid; E Kokmen; R J Ivnik; S N Thibodeau
Journal:  Am J Hum Genet       Date:  1994-04       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.